所有喘患者是否应该转换为单次维护和缓解疗法?
Gabriela Smicherko1, Amanda Albright, Kimmy Nguyen
1At the time this article was written, Gabriela Smicherko and Amanda Albright were doctor of pharmacy students at Wilkes University Nesbitt School of Pharmacy in Wilkes-Barre, Pa. Kimmy Nguyen is an assistant professor of pharmacy practice at Wilkes University and a clinical pharmacy specialist with Volunteers in Medicine of Wilkes-Barre. The authors have disclosed no potential conflicts of interest, financial or otherwise.
过度依赖短效β2-激动剂 (SABAs) 会增加喘发作的风险. 将吸入性皮质类固醇和formoterol用于维护和缓解提供了首选的喘管理策略.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 短效β2-激动剂 (SABA) 的过度使用与更糟糕的喘结果有关,包括恶化和死亡率.
- 吸入性皮质类固醇-formoterol联合治疗正在成为首选的喘管理方法.
研究的目的:
- 要突出在喘管理中使用布德索尼德-福莫特醇的临床考虑因素.
- 告知临床医生关于这种组合治疗的药理学和处方.
主要方法:
- 关于SABA过度使用和吸入性皮质类固醇-formoterol治疗的最新数据的审查.
- 对药理学,剂量和处方考虑的分析.
主要成果:
- 过度使用SABA与喘恶化和死亡率的增加有关.
- 布德胺-甲醇在维持喘和缓解喘方面具有双重作用.
结论:
- 临床医生必须了解SABA过度使用的风险.
- 布德胺-甲醇是控制喘的关键治疗选择,需要明智的处方实践.
相关概念视频
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Inhaled Medications
COPD: Management Using Bronchodilators and Corticosteroids
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.


